Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
Parkinson’s Disease (PD) is a neurological disease characterized by the progressive degeneration of the nigrostriatal dopaminergic pathway with consequent loss of neurons in the substantia nigra pars compacta and dopamine depletion. The cytoplasmic inclusions of α-synuclein (α-Syn), known as Lewy bo...
Main Authors: | Giovanni Schepici, Serena Silvestro, Placido Bramanti, Emanuela Mazzon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/13/4766 |
Similar Items
-
Efficacy of Sulforaphane in Neurodegenerative Diseases
by: Giovanni Schepici, et al.
Published: (2020-11-01) -
Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches
by: Giovanni Schepici, et al.
Published: (2020-03-01) -
Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials
by: Serena Silvestro, et al.
Published: (2020-01-01) -
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
by: Serena Silvestro, et al.
Published: (2020-11-01) -
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
by: Giovanni Schepici, et al.
Published: (2019-12-01)